个股网[www.geguw.com]方便的个股数据查询股票网 手机APP下载 | 手机访问 | 加入收藏 | 保存到桌面
个股网
个股网 股票数据查询
个股
查询
个股分析 股票行情 DDX查询 千股千评 高管减持 年报季报 披露时间 停复牌 财务指标 股本结构 十大股东 高管 主营业务 涨停揭秘 ...
当前位置: 个股网 > 股本结构 > 恒瑞医药(600276)

600276
恒瑞医药

个股分析 股票行情 千股千评 DDX查询 高管减持 大宗交易 高管名单 十大股东 停牌复牌
涨停揭秘 年报季报 披露时间 财报指标 主营业务 股本结构 个股分红 公告股吧 个股简介

600276[恒瑞医药] 股本结构 股本变动

股份流通受限表数值(万股)占比
流通受限股份479.430.08
已流通股份637420.8099.92
总股本637900.23100.00
流通股份分布情况表数值(万股)占比
人民币普通股(A股)637420.80100.00
境内上市外资股(B股)0.000.00
境外上市外资股(H股)0.000.00
其它已流通股份0.000.00
流通股份合计637420.80100.00
变更日期变更原因总股本(万股)已上市流通A股受限流通股份(万股)
2023-12-31定期报告637900.23637420.80479.43
2023-06-30定期报告637900.23637420.80479.43
2022-12-31定期报告637900.23637900.23
2022-06-30定期报告637900.23637900.23
2022-02-17回购637900.23637900.23
2021-12-31定期报告639601.19637900.231700.96
2021-12-08回购639601.19637900.231700.96
2021-10-25股权激励限售股份上市639747.76637900.231847.53
2021-06-30定期报告639747.76636751.762996.00
2021-06-11送转股639747.76636751.762996.00
2021-05-27回购533123.13530626.462496.67
2021-02-01股权激励限售股份上市533171.70530626.462545.24
2021-01-21股权激励限售股份上市533171.70530382.822788.89
2020-12-31定期报告533171.70529573.793597.91
2020-10-23股权激励533171.70529573.793597.91
2020-06-30定期报告530675.03529573.791101.24
2020-05-26送转股530675.03529573.791101.24
2020-04-22回购442229.20441311.49917.70
2020-02-03股权激励限售股份上市442281.42441311.49969.93
2020-01-20股权激励限售股份上市442281.42441094.321187.10
2019-12-31定期报告442281.42440391.501889.92
2019-06-30定期报告442281.42440391.501889.92
2019-05-30回购442281.42440391.501889.92
2019-03-29送转股442303.45440391.501911.95
2019-01-25股权激励368586.21366992.921593.29
2019-01-22股权激励限售股份上市368207.71366992.921214.80
2018-12-31定期报告368207.71366194.792012.92
2018-11-05回购368207.71366194.792012.92
2018-06-30定期报告368244.24366194.792049.45
2018-05-31送转股368244.24366194.792049.45
2018-01-31股权激励限售股份上市283264.80281688.301576.50
2018-01-18股权激励283264.80281630.851633.95
2017-12-31定期报告281688.30281630.8557.45
2017-09-22回购281688.30281630.8557.45
2017-07-25股权激励限售股份上市281688.98281630.8558.13
2017-06-30定期报告281688.98281228.44460.54
2017-06-29回购281688.98281228.44460.54
2017-06-01送转股281695.16281228.44466.72
2017-01-16股权激励限售股份上市234745.97234357.04388.93
2016-12-31定期报告234745.97234309.16436.81
2016-12-07回购234745.97234309.16436.81
2016-10-27回购234752.66234309.16443.50
2016-07-19股权激励限售股份上市234776.29234309.16467.13
2016-06-30定期报告234776.29233960.33815.96
2016-06-17送转股234776.29233960.33815.96
2016-01-22回购195646.91194966.94679.97
2016-01-21股权激励限售股份上市195649.91194966.94682.97
2015-12-31定期报告195649.91194913.75736.16
2015-07-17股权激励限售股份上市195649.91194913.75736.16
2015-06-30定期报告195649.91194511.631138.28
2015-06-16送转股195649.91194511.631138.28
2015-05-27股份回购150499.93149624.33875.60
2015-01-14股权激励150501.58149624.33877.25
2014-12-31定期报告150399.28149624.33774.95
2014-07-16股权激励150399.00149624.00775.00
2014-06-30定期报告149624.33149624.33
2014-05-15送股149624.33149624.33
2013-12-31定期报告136022.12136022.12
2013-07-05股权激励限售流通136022.12136022.12
2013-06-30定期报告136022.12135774.85247.27
2013-06-13送转股136022.12135774.85247.27
2012-12-31定期报告123656.47123431.68224.79
2012-07-05股权激励限售流通123656.47123431.68224.79
2012-06-30定期报告123656.47123206.88449.59
2012-05-30送转股123656.47123206.88449.59
2011-12-31定期报告112414.97112006.26408.72
2011-07-11股权激励限售流通112414.97112006.26408.72
2011-06-30112414.97112006.26408.72
2011-04-27送转股112414.97111733.78681.20
2010-12-31定期报告74943.3274489.19454.13
2010-07-28股权激励74943.3274489.19454.13
2010-03-18送转股74489.1974489.19
2009-06-22有限售条件的流通股上市62074.3262074.32
2009-05-04送转股62074.3242490.4819583.85
2008-06-20有限售条件的流通股上市51728.6035408.7316319.87
2008-04-14送转股51728.6029970.8721757.73
2007-06-20有限售条件的流通股上市43107.1724975.7218131.44
2007-04-03送转股43107.1716224.0026883.17
2006-08-30送转股33159.3612480.0020679.36
2006-06-20股权分置25507.209600.0015907.20
2003-03-27股权转让25507.200.00
2002-05-22送股上市(10送2股)25507.207680.00
2001-05-11送转股上市(10送3转增3股)21256.006400.00
2000-10-18新股上市0.004000.00
恒瑞医药[600276]净利润增长率
恒瑞医药[600276]净利润增长率
恒瑞医药[600276]主营业务收入(亿元)
恒瑞医药[600276]主营业务收入(亿元)
恒瑞医药[600276]每股资本公积金
恒瑞医药[600276]每股资本公积金
恒瑞医药[600276]现金流量比率
恒瑞医药[600276]现金流量比率
个股网提示:本站展示的广告不代表本站观点!由此引起的一切法律责任均与本站无关,股市有风险,投资需谨慎。
本站所有内容仅供参考,不构成投资建议,据此操作,风险自担。本站不为所提供数据的错误或因依此信息所采取的任何行为负责。
联系我们:zyrf8@hotmail.com